SUPN

Supernus Pharmaceuticals Inc

Jun 05 • 04:00PM ET

44.75

+0.05 0.11 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • Mid • NASD

Peers: INDV ALKS AMRX KNSA LNTH NBIX ACAD TLX BIIB VRTX

| Held by: IJR VTI VB IWM VBR VXF SPSM IWN IJT VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.51	Insider Own	6.15%	Shs Outstand	58.04M	Perf Week	-3.10%
Market Cap	2.60B	Forward P/E	11.42	EPS next Y	3.92	Insider Trans	-5.36%	Shs Float	54.47M	Perf Month	-13.02%
Enterprise Value	2.25B	PEG	0.61	EPS next Q	0.43	Inst Own	99.67%	Short Float	8.69%	Perf Quarter	-16.93%
Income	-29.02M	P/S	3.34	EPS this Y	-23.13%	Inst Trans	1.51%	Short Ratio	7.33	Perf Half Y	-0.02%
Sales	776.83M	P/B	2.41	EPS next Y	57.64%	ROA	-2.04%	Short Interest	4.73M	Perf YTD	-9.96%
Book/sh	18.55	P/C	6.76	EPS next 5Y	18.58%	ROE	-2.75%	52W High	59.68 -25.02%	Perf Year	38.37%
Cash/sh	6.62	P/FCF	31.58	EPS past 3/5Y	- -	ROIC	-2.62%	52W Low	30.83 45.15%	Perf 3Y	32.87%
Dividend Est.	-	EV/EBITDA	45.35	Sales past 3/5Y	2.52% 6.68%	Gross Margin	76.89%	Volatility	3.16% 3.57%	Perf 5Y	49.77%
Dividend TTM	-	EV/Sales	2.90	EPS Y/Y TTM	-145.12%	Oper. Margin	-6.13%	ATR (14)	1.72	Perf 10Y	129.13%
Dividend Ex-Date	-	Quick Ratio	1.72	Sales Y/Y TTM	16.29%	Profit Margin	-3.74%	RSI (14)	35.49	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	1.96	EPS Q/Q	81.20%	SMA20	-6.32%	Beta	0.55	Target Price	62.83
Payout	-	Debt/Eq	0.04	Sales Q/Q	38.63%	SMA50	-9.03%	Rel Volume	0.86	Prev Close	44.70
Employees	778	LT Debt/Eq	0.03	Earnings	May 05 AMC	SMA200	-8.66%	Avg Volume	645.25K	Price	44.75
IPO	May 01, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	102.29% 7.67%	Trades		Volume	552,808	Change	0.11%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)